SEC Form 4 · accession 0001145443-15-001185
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Errol B Desouza
Officer — CEO · Director
Period of report
Sep 30, 2015
Accepted (ET)
Oct 2, 2015 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 30, 2015 | M | 131,128 | — | A | 202,885 | D | |
| Common Stock | Sep 30, 2015 | F | 43,469 | $0.44 | D | 159,416 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Sep 30, 2015 | M | — | A | — | — | Common Stock | — | 0 | D |
Explanation of responses
- F1Each Restricted Stock Unit was the economic equivalent of one share of common stock.
- F2The shares of common stock were distributed upon settlement of 131,128 Restricted Stock Units that were granted on November 11, 2014 in place of a discretionary cash bonus for the fiscal year ended September 30, 2014.